Use of melanotan I and II in the general population.

@article{EvansBrown2009UseOM,
  title={Use of melanotan I and II in the general population.},
  author={Michael Evans-Brown and Rob Dawson and Martin Chandler and Jim McVeigh},
  journal={BMJ},
  year={2009},
  volume={338},
  pages={
          b566
        }
}
  • Michael Evans-Brown, Rob Dawson, +1 author Jim McVeigh
  • Published in BMJ 2009
  • Medicine
  • Is unlicensed, unregulated, and potentially harmful In 2002 the media reported that the demand for synthetic melanocortin analogues melanotan I and melanotan II (melanotans) was likely to increase in the general population.1 This was mainly because of their ability to tan the skin, and—in the case of melanotan II—induce penile erections and increase sexual desire.2 In 2008, several workers at needle and syringe programmes in the United Kingdom contacted the substance use team at the Centre for… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 26 CITATIONS

    An in-depth case examination of an exotic dancer's experience of melanotan.

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Cult of the body beautiful: at what cost?

    VIEW 2 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Eruptive Melanocytic Nevi: A Review

    VIEW 1 EXCERPT
    CITES BACKGROUND

    ERUPTIVE MELANOCYTIC NEVI

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Eruptive Dysplastic Nevi Following Melanotan Use

    • Nevos displásicos
    • 2017
    VIEW 2 EXCERPTS
    CITES BACKGROUND